MEDS Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Sep 13, 2017)
Marijuana Effective Drug Studies Act of 2017 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
What just happenedSep 13, 2017
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)
Who’s behind it
- Introduced in SenateSep 13, 2017
- Sep 13, 2017IntroReferral
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)
Judiciary Committee - Sep 13, 2017IntroReferral10000
Introduced in Senate